VERAPAMIL HCI
- Product NDC
- 51662-1442
- 11-digit product format
- 516621442
- Labeler code
- 51662
- Product ID
- 51662-1442_12506f53-54b9-53d1-e063-6294a90addc5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HCI
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- NDA018925
- Marketing category
- NDA
- Marketing start
- 2019-12-22
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 2.5 mg/mL
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VERAPAMIL HCI
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V3888OEY5R |
| Rxcui | 1665057 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1442-1 | VERAPAMIL HCI | 2 mL in 1 VIAL | INJECTION | 2 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1442 | VERAPAMIL HCI INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240228_9a4f12ec-fe1c-a1b9-e053-2a95a90ac8e4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1442-1 | 51662144201 | 2 mL in 1 VIAL (51662-1442-1) | 2 ml | 2019-12-22 | 0000-00-00 | No | No | Current |